Merck KGaA has teamed up with Flagship Pioneering's Valo Health on an ambitious project to apply AI to the discovery of novel drug targets and therapeutics for Parkinson's disease. The partnership ...
LONDON, December 10, 2025--(BUSINESS WIRE)--Vertical Aerospace (NYSE: EVTL) ("Vertical" or "the Company"), a global aerospace and technology company that is pioneering electric aviation, today ...
Vertical Aerospace has unveiled Valo, the certification-intent version of its VX4 prototype, which features multiple updates, including aerodynamic improvements, over its predecessor. UK-headquartered ...
FRANKFURT (Reuters) -Germany's Merck KGaA on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration focused on Parkinson's and related diseases that is potentially ...
Valo Health Announces Collaboration with Merck KGaA, Darmstadt, Germany to Discover and Develop Novel Treatments for Parkinson’s Disease and Related Disorders Partnership includes upfront and ...
Merck KGaA has signed a drug discovery partnership with Valo Health, becoming the latest big pharma to enlist the services of the tech company to identify the next big therapeutic. The strategic ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A growing Lexington-based ...
VALO,a newly launched sourcing platform backed by 25 years of industry expertise,connects US buyers directly with verified Vietnamese manufacturers.By offering a free-to-use system that emphasizes ...
Valo Therapeutics Oy announces that it has successfully secured a financing round of €19 million, part of which was raised in Europe and part in Australia, to clinically develop its innovative immune ...
“I want to see the moulds,” says HIM singer Ville Valo, wagging his finger and raising his beer to his lips. “It’s important to me that it’s the right shape. I want it to be a quality product. I’m ...
Jan 8 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to develop new treatments for ...
Danish drugmaker Novo Nordisk (NVO) (OTCPK:NONOF) and AI-focused biotech Valo Health announced Wednesday an agreement to expand their existing collaboration to discover and develop new treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback